236 related articles for article (PubMed ID: 27714952)
1. Detection of 5α-androst-2-en-17-one and variants: Identification of main urinary metabolites in human urine samples by GC-MS and NMR.
Ayotte C; Sylvestre A; Charlebois A; Poirier D
Drug Test Anal; 2016 Nov; 8(11-12):1174-1185. PubMed ID: 27714952
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS.
Fragkaki AG; Angelis YS; Kiousi P; Georgakopoulos CG; Lyris E
J Mass Spectrom; 2015 May; 50(5):740-8. PubMed ID: 26259657
[TBL] [Abstract][Full Text] [Related]
3. Seized designer supplement named "1-Androsterone": identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination.
Parr MK; Opfermann G; Geyer H; Westphal F; Sönnichsen FD; Zapp J; Kwiatkowska D; Schänzer W
Steroids; 2011 May; 76(6):540-7. PubMed ID: 21310167
[TBL] [Abstract][Full Text] [Related]
4. Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing.
Piper T; Emery C; Thomas A; Saugy M; Thevis M
Anal Bioanal Chem; 2013 Jun; 405(16):5455-66. PubMed ID: 23568614
[TBL] [Abstract][Full Text] [Related]
5. Detection of androst-4-ene-3,6,17-trione (6-OXO) and its metabolites in urine by gas chromatography-mass spectrometry in relation to doping analysis.
Van Thuyne W; Van Eenoo P; Mikulcíková P; Deventer K; Delbeke FT
Biomed Chromatogr; 2005 Nov; 19(9):689-95. PubMed ID: 15828056
[TBL] [Abstract][Full Text] [Related]
6. Development of criteria for the detection of adrenosterone administration by gas chromatography-mass spectrometry and gas chromatography-combustion-isotope ratio mass spectrometry for doping control.
Brooker L; Parr MK; Cawley A; Flenker U; Howe C; Kazlauskas R; Schänzer W; George A
Drug Test Anal; 2009 Nov; 1(11-12):587-95. PubMed ID: 20355175
[TBL] [Abstract][Full Text] [Related]
7. Detection and metabolic investigations of a novel designer steroid: 3-chloro-17α-methyl-5α-androstan-17β-ol.
Cawley AT; Blakey K; Waller CC; McLeod MD; Boyd S; Heather A; McGrath KC; Handelsman DJ; Willis AC
Drug Test Anal; 2016 Jul; 8(7):621-32. PubMed ID: 27443417
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies of androst-4-ene-3,6,17-trione in horses by gas chromatography-mass spectrometry.
Leung GN; Tang FP; Wan TS; Wong CH; Lam KK; Stewart BD
Biomed Chromatogr; 2010 Jul; 24(7):744-51. PubMed ID: 19882746
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of novel long-term metabolites of oxymesterone and mesterolone in human urine by application of selected reaction monitoring GC-CI-MS/MS.
Polet M; Van Gansbeke W; Geldof L; Deventer K; Van Eenoo P
Drug Test Anal; 2017 Nov; 9(11-12):1673-1684. PubMed ID: 28296258
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites.
Kohler M; Parr MK; Opfermann G; Thevis M; Schlörer N; Marner FJ; Schänzer W
Steroids; 2007 Mar; 72(3):278-86. PubMed ID: 17207827
[TBL] [Abstract][Full Text] [Related]
11. Use of gas chromatographic-mass spectrometric techniques in studies of androst-16-ene and androgen biosynthesis in human testis; cytosolic specific binding of 5alpha-androst-16-en-3-one.
Kwan TK; Kraevskaya MA; Makin HL; Trafford DJ; Gower DB
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):137-46. PubMed ID: 9182868
[TBL] [Abstract][Full Text] [Related]
12. Determination of mepitiostane metabolites in human urine by liquid chromatography/tandem mass spectrometry for sports drug testing.
Okano M; Sato M; Kojima A; Kageyama S
J Pharm Biomed Anal; 2015 Nov; 115():236-44. PubMed ID: 26247800
[TBL] [Abstract][Full Text] [Related]
13. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine.
Sobolevsky T; Rodchenkov G
J Steroid Biochem Mol Biol; 2012 Feb; 128(3-5):121-7. PubMed ID: 22142641
[TBL] [Abstract][Full Text] [Related]
14. New oxymesterone metabolites in human by gas chromatography-tandem mass spectrometry and their application for doping control.
Yang S; Lu J; Xu Y; Wang X
Drug Test Anal; 2016 Jul; 8(7):633-43. PubMed ID: 26197789
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of androst-4-ene-3,6,17-trione and metabolites in human urine after the administration of a food supplement by liquid chromatography/ion trap-mass spectrometry.
Deventer K; Van Eenoo P; Mikulcíková P; Van Thuyne W; Delbeke FT
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):21-6. PubMed ID: 16213800
[TBL] [Abstract][Full Text] [Related]
16. In vivo metabolism of the designer anabolic steroid hemapolin in the thoroughbred horse.
Waller CC; Weththasinghe SA; McClure L; Cawley AT; Suann C; Suann E; Sutherland E; Cooper E; Heather A; McLeod MD
Drug Test Anal; 2020 Jun; 12(6):752-762. PubMed ID: 31950580
[TBL] [Abstract][Full Text] [Related]
17. Determination of the deuterium/hydrogen ratio of endogenous urinary steroids for doping control purposes.
Piper T; Thevis M; Flenker U; Schänzer W
Rapid Commun Mass Spectrom; 2009 Jul; 23(13):1917-26. PubMed ID: 19462405
[TBL] [Abstract][Full Text] [Related]
18. Investigations on the in vivo metabolism of 5α-androst-2-en-17-one.
Piper T; Fusshöller G; Schänzer W; Thevis M
Rapid Commun Mass Spectrom; 2022 Sep; 36(17):e9343. PubMed ID: 35737649
[TBL] [Abstract][Full Text] [Related]
19. Capillary gas chromatography with chemical ionization negative ion mass spectrometry in the identification of odorous steroids formed in metabolic studies of the sulphates of androsterone, DHA and 5alpha-androst-16-en-3beta-ol with human axillary bacterial isolates.
Gower DB; Mallet AI; Watkins WJ; Wallace LM; Calame JP
J Steroid Biochem Mol Biol; 1997; 63(1-3):81-9. PubMed ID: 9449209
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric description of novel oxymetholone and desoxymethyltestosterone metabolites identified in human urine and their importance for doping control.
Sobolevsky T; Rodchenkov G
Drug Test Anal; 2012 Sep; 4(9):682-91. PubMed ID: 22945829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
